Literature DB >> 12928117

Endoscopic ultrasound evaluation in the diagnosis and staging of lung cancer.

Annette Fritscher-Ravens1.   

Abstract

The detection of mediastinal lymph node metastases in patients with lung cancer is most important. These nodes may be used for tissue diagnosis of the malignancy, if sampling techniques of the primary have failed. Their presence implies a stage III disease and may exclude a patient from surgery. CT is the standard imaging, but is relatively poor at staging the mediastinum (overall sensitivity: 50-70%), and is especially unreliable for lesions <1 cm. PET is a new physiological imaging technique, which seems to be superior to CT (sensitivity: 67-100%). Transesophageal EUS delivers high resolution imaging, offers the advantage of simultaneous tissue sampling (EUS-FNA sensitivity: 84-94%), but is limited to the posterior mediastinum. This review compares the diagnostic value of CT, PET and EUS as well as the different tissue sampling methods for mediastinal metastases with EUS-FNA. The technique of EUS and FNA is described, and a special interest is taken to stress out the different areas of the mediastinum accessible for each of the tissue sampling methods as well as the pros and cons for its use. Advantages and disadvantages of EUS-FNA are shown and the new efforts described to improve the outcome of EUS-FNA by adding molecular methods for the detection of micrometastases.

Entities:  

Mesh:

Year:  2003        PMID: 12928117     DOI: 10.1016/s0169-5002(03)00229-0

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

Review 1.  Role of endobronchial ultrasound-guided transbronchial needle aspiration in the management of lung cancer.

Authors:  Kazuhiro Yasufuku; Takahiro Nakajima; Taiki Fujiwara; Masako Chiyo; Akira Iyoda; Shigetoshi Yoshida; Makoto Suzuki; Yasuo Sekine; Kiyoshi Shibuya; Ichiro Yoshino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-06-18

2.  Diagnostic accuracies of endoscopic ultrasound-guided fine-needle aspiration with distinct negative pressure suction techniques in solid lesions: A retrospective study.

Authors:  Ronghua Wang; Jinlin Wang; Yawen Li; Yaqi Duan; Xiaoli Wu; Bin Cheng
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

3.  Extraintestinal Applications of Endoscopic Ultrasound.

Authors:  Rayburn Rego
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-04

4.  Endoscopic ultrasound-guided fine-needle aspiration in patients with lymphadenopathy suspected of recurrent malignancy after curative treatment.

Authors:  Takuji Iwashita; Ichiro Yasuda; Shinpei Doi; Masanori Nakashima; Hisashi Tsurumi; Yoshinobu Hirose; Tsuyoshi Takami; Masamichi Enya; Tsuyoshi Mukai; Takaya Ohnishi; Keisuke Iwata; Eiichi Tomita; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

5.  Oesophageal endoscopic ultrasound with fine needle aspiration improves and simplifies the staging of lung cancer.

Authors:  H Kramer; J W G van Putten; W J Post; H M van Dullemen; A H H Bongaerts; J Pruim; A J H Suurmeijer; T J Klinkenberg; H Groen; H J M Groen
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

6.  Strategy for esophageal non-epithelial tumors based on a retrospective analysis of a single facility.

Authors:  Tomoaki Aoki; Tetsu Nakamura; Taro Oshikiri; Hiroshi Hasegawa; Masashi Yamamoto; Yoshiko Matsuda; Shingo Kanaji; Kimihiro Yamashita; Takeru Matsuda; Yasuo Sumi; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Esophagus       Date:  2018-06-23       Impact factor: 4.230

7.  Role of EUS-FNA in Recurrent Lung Cancer: Maximum Results with Minimum (minimally invasive) Effort.

Authors:  Ana M Ioncica; Mehmet Bektas; Rei Suzuki; Adrian Saftoiu; Everson L A Artifon; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2013-04       Impact factor: 5.628

8.  Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma.

Authors:  Fei Xiong; Guan-Hua Wu; Bing Wang; Yong-Jun Chen
Journal:  Cancer Cell Int       Date:  2021-08-04       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.